← 返回

NK 细胞相关长非编码 RNA 揭示结直肠癌免疫微环境的异质性

英文原题:NK cell-associated long non-coding RNAs reveal heterogeneity of colorectal cancer immune microenvironment.

查看英文原题

NK cell-associated long non-coding RNAs reveal heterogeneity of colorectal cancer immune microenvironment.

PubMed 2025/11/13(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本研究系统阐明了 NK 相关 lncRNA 在 CRC 免疫微环境中的调控作用,为 CRC 免疫治疗提供了新的分子靶点和分层策略。

研究思路结论见上方概要

被诊断为结直肠癌(CRC)的个体常面临严峻的预后,并且对常规治疗方案反应不佳。免疫治疗,尤其是以自然杀伤(NK)细胞为中心的治疗模式,代表了CRC治疗中一个新兴的前沿领域。本研究开发了一个经过验证的预后模型,使用NK相关长链非编码RNA(lncRNA)来预测CRC的结局。

整合单细胞RNA-seq(GSE146771_Smartseq2)与TCGA-COAD/READ bulk转录组数据,我们鉴定了NK特异性基因及相关lncRNA。多步骤分析方法——包括单因素Cox回归初步筛选、LASSO回归减少过拟合、多因素Cox回归最终模型优化——产生了一个稳健的16-lncRNA预后特征,具有高预测准确性。

该模型在训练集、验证集和76个独立临床样本中均表现出稳健的预测性能。机制研究揭示,AC010319.3在NK细胞中高表达,通过抑制IFN-和颗粒酶B的表达来减弱NK细胞的细胞毒性,从而促进CRC细胞的增殖和侵袭。

展开英文摘要原文

Integrating single-cell RNA-seq (GSE146771_Smartseq2) and TCGA-COAD/READ bulk transcriptomic data, we identified NK-specific genes and correlated lncRNAs. A multi-step analytical approach-including univariate Cox regression for preliminary screening, LASSO regression to minimize overfitting, and multivariate Cox regression for final model optimization-yielded a robust 16-lncRNA prognostic signature with high predictive accuracy.

This model demonstrated robust predictive performance across the training set, validation set, and 76 independent clinical samples. Mechanistic investigations revealed that AC010319.3 is highly expressed in NK cells, where it attenuates NK cell cytotoxicity by suppressing the expression of IFN- and granzyme B, thereby promoting the proliferation and invasion of CRC cells. DISCUSSION: This study systematically delineates the regulatory role of NK-associated lncRNAs within the CRC immune microenvironment, offering novel molecular targets and stratification strategies for CRC immunotherapy.

论文信息

作者
Li Y、Xia C、Li J、Qin J、Shi F、Zhang W、Liang D、Shu Y
单位
Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.China
期刊
Frontiers in immunology2025
原文标识
PubMed 41322425 · DOI 10.3389/fimmu.2025.1615942